PER 2.00% 7.4¢ percheron therapeutics limited

..Aceshigh...Seriously you are the number one fan of ANP but...

  1. 1,659 Posts.
    lightbulb Created with Sketch. 1

    ..Aceshigh

    ...Seriously you are the number one fan of ANP but really i need to ask u a couple of questions on ATL1103...

    ...Do u agree that ANP will need cash in the very near term given that phase 2 and 3 trials to follow are extremely expensive to complete..

    ...Do u also agree that to complete phase 2 and 3 would be at least 3 years away at the earliest......

    ...Do you also agree that saftey concerns of Antisense ATL 1101.1102,1103 wont be known till end phase 3 of each drug....In February 2010, Isis announced its cholesterol-lowering antisense therapy, mipomersen, had met its endpoints in a phase 3 trial of 124 patients, butlingering concerns related to high liver enzyme levels in some trial participants—a safety signal that had been noted in previous trials—dampened investor enthusiasm. But even if elevated liver....
    http://www.nature.com/nbt/journal/v28/n4/full/nbt0410-295.html

    ...RB
  2. This thread is closed.

    You may not reply to this discussion at this time.

 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.